• Hospital use
  • Home use
  • Acoustic therapy
  • PEMF therapy

MAGOFON has a triple therapeutic effect provided by the combined action of pulsed electromagnetic field, gentle vibration massage and acoustic signal.

MAGOFON is used for treating the following diseases:

  • Musculoskeletal system disoders (osteochondrosis, osteoarthritis, scapulohumeral periarthrosis, arthritis, bursitis, myositis);
  • Neurological disorders (neuritis, trigeminal neuralgia);
  • Post-traumatic conditions (broken bones, internal injuries of joints, soft tissue contusion, hematoma, post-traumatic edema, fiber band and muscles damages).

How it works
  1. Magofon improves tissue metabolism and activates regeneration processes;
  2. Magofon significantly improves blood supply of the affected organs, brings oxygen and nutrients to the cells and helps to excrete waste;
  3. Magofon contributes to drug absorption in the affected tissues and enhances edema dispersion;
  4. Magofon reduces sensitivity of peripheral nerve receptors, which results in pain relief;
  5. Magofon eases emotional and muscular tension;
  6. In cases of muscle injuries, sprains, strains and bruises:
    • Magofon relieves pain and disperses swelling within the first minutes of use;
    • Magofon shortens healing time;
    • Magofon improves physical performance efficiency.

Why choose MAGOFON?
  1. Magofon treats the disease itself, not only its symptoms;
  2. Magofon facilitates healing both of acute stage and chronic diseases;
  3. Magofon has been approved for children from 1 year and older;
  4. Magofon shows noticeable positive effect after the first sessions;
  5. Magofon is easy-to-use, requires no special medical skills;
  6. Due to the wide application spectrum Magofon is a heal-all remedy for the whole family.

Technical Features
  1. Peak value of magnetic induction on the device working surface is (30 ± 9) mT.
  2. Magnetic induction maximum value at the distance of 0.5 m from the device working surface does not exceed 0.5 mT.
  3. Acoustic range frequency is (0.02-20) kHz.
  4. Spectral density of the acoustic signal sound pressure at a distance of 300 mm from the device (in the frequency band from 0.02 to 20 kHz) is not more than 1 Pa.
  5. The device is designed for 6 hour operation in intermittent duty mode (operation mode - 20 min., break - 30 min.).
  6. Device body temperature after one operating cycle (operation mode - 20 min., break - 30 min.) does not exceed 410°C.
  7. The exterior surfaces of the device component parts are resistant to chemical disinfection by any kind of solution approved for use in medical practice for plastic.
  8. Average service life is 5 years.

  • Purulent inflammatory diseases in acute and febrile states
  • Blood disorders: systemic blood diseases, bleeding and bleeding liability, liability to thrombosis , blood clots, acute thrombophlebitis
  • Cardiovascular system diseases: severe hypotension, severe coronary heart disease progression, early post-infraction period, the acute phase of cerebrovascular circulation disorders
  • Pregnancy
  • Oncological diseases
  • Thyrotoxicosis
  • Diencephalic syndrome
  • Pacemaker
ATTENTION! Prior to first usage of the device, please study this Operating Manual carefully, and follow its instructions during further use to ensure proper treatment procedure and effectiveness.    0.49 MB Download

Similar Products

© Yelatma Instrument Making Enterprise, JSC, 2009—2019
The production is certified: EN ISO 13485:2016, MDD 93/42/EEC (TUV NORD CERT GmbH, Germany)
BIN 1026200861620 from 20.11.02 serial 62 N 000337033